| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |